Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Juvenile Idiopathic Arthritis (SJIA)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02296424
What this trial is testing

SS-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab

Who this might be right for
Systemic Juvenile Idiopathic Arthritis (SJIA)
Novartis Pharmaceuticals 182
Large-scale testing (Phase 3)Looking for participantsNCT05609630
What this trial is testing

Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.

Who this might be right for
Juvenile Idiopathic Arthritis
AbbVie 90
Testing effectiveness (Phase 2)Looking for participantsNCT07203001
What this trial is testing

A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease

Who this might be right for
Still´s Disease
Novartis Pharmaceuticals 30
Large-scale testing (Phase 3)Study completedNCT00144599
What this trial is testing

Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Chugai Pharmaceutical 56
Large-scale testing (Phase 3)Ended earlyNCT00078806
What this trial is testing

Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis

Who this might be right for
Juvenile Rheumatoid Arthritis
Amgen 19
Large-scale testing (Phase 3)Ended earlyNCT03265132
What this trial is testing

Evaluate Efficacy and Safety of Anakinra in the Treatment of Still's Disease (SJIA and AOSD)

Who this might be right for
Still's Disease, Adult-OnsetStill's Disease, Juvenile-Onset
Swedish Orphan Biovitrum 13
Early research (Phase 1)Study completedNCT02165345
What this trial is testing

Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 82
Early research (Phase 1)Study completedNCT01455701
What this trial is testing

Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA)

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 11
Testing effectiveness (Phase 2)Study completedNCT03311854
What this trial is testing

Investigate the Safety and Efficacy of Emapalumab, an Anti-IFN-gamma mAb in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHLH)

Who this might be right for
Macrophage Activation SyndromeLymphohistiocytosis, HemophagocyticArthritis, Juvenile+1 more
Swedish Orphan Biovitrum 14
Large-scale testing (Phase 3)Study completedNCT05001737
What this trial is testing

Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE

Who this might be right for
Macrophage Activation SyndromeSecondary Hemophagocytic LymphohistiocytosisStill Disease+4 more
Swedish Orphan Biovitrum 33
Not applicableNot Yet RecruitingNCT07814963
What this trial is testing

Clinical Features and Treatment of Systemic JIA in Children

Who this might be right for
Systemic Juvenile Idiopathic Arthritis (sJIA)Systemic Juvenile Idiopathic Arthritis
Sohag University 50
Large-scale testing (Phase 3)Study completedNCT00144612
What this trial is testing

Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Chugai Pharmaceutical 60
Post-approval studies (Phase 4)Study completedNCT01734382
What this trial is testing

Decreased Dose Frequency in Participants With Systemic Juvenile Arthritis Who Experience Laboratory Abnormalities During Treatment With RoActemra/Actemra (Tocilizumab)

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 35
Testing effectiveness (Phase 2)Study completedNCT00534495
What this trial is testing

Safety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and Young Adults

Who this might be right for
Juvenile Idiopathic Arthritis
Montefiore Medical Center 71
Large-scale testing (Phase 3)Study completedNCT02334748
What this trial is testing

Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies

Who this might be right for
Systemic Juvenile Idiopathic ArthritisHereditary Periodic Fevers
Novartis Pharmaceuticals 31
Large-scale testing (Phase 3)Study completedNCT00891046
What this trial is testing

An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Novartis Pharmaceuticals 270
Large-scale testing (Phase 3)Study completedNCT00889863
What this trial is testing

Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis With Active Flare
Novartis Pharmaceuticals 177
Large-scale testing (Phase 3)Study completedNCT00339157
What this trial is testing

Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS

Who this might be right for
Systemic-Onset Juvenile Idiopathic Arthritis
Institut National de la Santé Et de la Recherche Médicale, France 24
Not applicableLooking for participantsNCT05925452
What this trial is testing

To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis.

Who this might be right for
Active Systemic Juvenile Idiopathic Arthritis
Changchun GeneScience Pharmaceutical Co., Ltd. 290
Testing effectiveness (Phase 2)Looking for participantsNCT02991469
What this trial is testing

A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)

Who this might be right for
Juvenile Idiopathic Arthritis
Sanofi 51
Next Page